Global At-home Drug of Abuse Market Outlook to 2023 - An $832 Million Opportunity, with the Rising Addiction for Synthetic Cannabinoids, Bath Salts and Other Emerging Drugs - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 27, 2019--The “At-Home Drug of Abuse - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023” report has been added to ResearchAndMarkets.com’s offering.
Global at-home DOA testing market is projected to attain a size of $831.9 million by 2023, the market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
On the basis of various types of products, the at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers. The market for rapid DOA test kits is expected to witness faster growth during the forecast period, attributed to the increasing adoption of various types of rapid DOA test kits, including test cups and dip cards. Also, these test kits are much cheaper as compared to breath analyzers.
Further, the rapid DOA test kits are bifurcated into test cups, test strips, test dip cards, and other types of kits. Amongst all these, the DOA test cups dominated the global rapid DOA test kits market in 2017. Extensive use of test cups for at-home urine drug testing is a key factor driving the market for this product category.
Samples used for at-home DOA testing are urine, saliva, hair, and other different types of samples. Of these, the products using urine as a sample are expected to witness the fastest growth in the at-home DOA testing market during the forecast period. DOA detection through urine sample is the easiest and most affordable way of at-home DOA testing. It is, therefore, the most commonly used method to analyze the presence of illegal and prescribed drugs in the body.
During the forecast period, the at-home DOA testing market is forecasted to witness the fastest growth in APAC, at a CAGR of 11.0%. This growth is attributed to the rising consumption of illicit drugs in the region. Also, the region is a large producer and trader of illicit drugs, including opium, heroin, amphetamine-type stimulants (ATS), and methamphetamines.
Besides, the limited availability of data on drug abuse within the region has necessitated the development and implementation of government initiatives on drug testing, which in turn, would contribute to the growth of the market in APAC in the coming years. For instance, a number of United Nations Office on Drugs and Crime (UNODC) programs have improved data collection networks, particularly in East and Southeast Asia. However, populous countries, including India and China, in the APAC region face a significant data gap, which requires government intervention. The increasing governments’ initiatives to control drugs abuse lead the growth of the APAC at-home DOA testing market during the forecast period.
The companies operating in the at-home DOA testing industry are acquiring other firms and establishing their presence in different economies to increase their market share. Abbott Laboratories (Abbott) being a major player in the production of at-home DOA testing products acquired Alere Inc. in 2017, to increase its share in the point-of-care testing diagnostics market. The addition of this business aligns with Abbott’s strategy for the growth of company and complements the leadership positions across its other businesses, which include medical devices, nutritional supplements, and pharmaceuticals.
- Rising Addiction for Synthetic Cannabinoids, Bath Salts and Other Emerging Drugs
- Increased Production and Trade of Illicit Drugs Worldwide
- Growing Use of Illicit Drugs Amongst Teenagers
- Initiatives by Government Organizations to Reduce the Level of Drug Abuse
- Legalization of Illicit Drugs
- Social Issues Associated With Substance Use Testing
- Inefficiency of Testing Products to Detect Designer Drugs
- Rising Awareness About DOA Testing in Emerging Economies
- Alternative Substance Addiction from Common Household Products
- UCP Biosciences Inc.
- Orient New Life Medical Co. Ltd.
- Express Diagnostics Int’l Inc.
- Assure Tech (Hangzhou) Co. Ltd.
- Psychemedics Corporation
- Confirm BioSciences
- Phamatech Inc.
- Home Health (U.K.) Ltd.
- Quest Products Inc.
- Abbott Laboratories
For more information about this report visit https://www.researchandmarkets.com/research/4bdw78/global_athome?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190227005418/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Addiction Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/27/2019 06:55 AM/DISC: 02/27/2019 06:55 AM